Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer

ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.

Saved in:
Bibliographic Details
Main Authors: Araújo,David Felipe B., Cavalcanti,Iago D. L., Larrazabal-Hadj-Idris,Bruna R., Peres,Adrya Lúcia
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Patologia Clínica 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1676-24442020000100421
record_format ojs
spelling oai:scielo:S1676-244420200001004212020-06-29Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancerAraújo,David Felipe B.Cavalcanti,Iago D. L.Larrazabal-Hadj-Idris,Bruna R.Peres,Adrya Lúcia neoplasm antineoplastic hematology toxicity ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.info:eu-repo/semantics/openAccessSociedade Brasileira de Patologia Clínica Jornal Brasileiro de Patologia e Medicina Laboratorial v.56 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421en10.5935/1676-2444.20200038
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Araújo,David Felipe B.
Cavalcanti,Iago D. L.
Larrazabal-Hadj-Idris,Bruna R.
Peres,Adrya Lúcia
spellingShingle Araújo,David Felipe B.
Cavalcanti,Iago D. L.
Larrazabal-Hadj-Idris,Bruna R.
Peres,Adrya Lúcia
Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
author_facet Araújo,David Felipe B.
Cavalcanti,Iago D. L.
Larrazabal-Hadj-Idris,Bruna R.
Peres,Adrya Lúcia
author_sort Araújo,David Felipe B.
title Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_short Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_full Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_fullStr Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_full_unstemmed Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
title_sort hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer
description ABSTRACT Introduction and objective: We verified the main hematological and biochemical alterations during the chemotherapy treatment for women with cervical cancer. Material and method: A retrospective, analytical and cross-sectional test was performed. The sample consisted of 39 medical records of women who underwent chemotherapy in the period from January to December 2016. The effects of hematological toxicities were evaluated according to erythrogram, leukogram, and platelet parameters, in relation to biochemical toxicities, using levels of serum marker (urea, creatinine, transaminases). Results: It was evidenced that among the chemotherapy protocols used, cisplatin showed a leukogram and plateletgram of 1.06 and 2.09 chances, respectively, for the development of leucopenia and thrombocytopenia during treatment. Conclusion: It was not possible to identify the degree of toxicity of the adverse effects of the treatment, because when these effects were registered in the medical record, they appeared without description, making it difficult to evaluate the degree of toxicity presented.
publisher Sociedade Brasileira de Patologia Clínica
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100421
work_keys_str_mv AT araujodavidfelipeb hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT cavalcantiiagodl hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT larrazabalhadjidrisbrunar hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
AT peresadryalucia hematologicalandbiochemicaltoxicityanalysisofchemotherapyinwomendiagnosedwithcervicalcancer
_version_ 1756427559051984896